SCHEMBL18256149

SCHEMBL18256149

Cc1cc(CCOS(C)(=O)=O)on1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
VHL P40337 2/20 0.39
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
MMP9 P14780 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NR1I2 O75469 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HCAR2 Q8TDS4 1/20 0.33
EPHX2 P34913 1/20 0.33
PYCR1 P32322 1/20 0.33
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18255943 0.90 NR1I2 (0.43) KMT2AMEN1VHLALDH1A1KDM4E
SCHEMBL1941686 0.83 KMT2A (0.51) KMT2AMEN1VHLALDH1A1HCAR2
SCHEMBL18256140 0.81 PPARA (0.37) KMT2AALDH1A1KDM4EUSP2LMNA
SCHEMBL26659535 0.78 HPGD (0.43) KMT2AMEN1ALDH1A1KDM4ERAB9A
SCHEMBL26807401 0.77 VHL (0.41) KMT2AMEN1VHLALDH1A1TSHR
SCHEMBL14293902 0.75 MEN1 (0.46) KMT2AMEN1VHLALDH1A1NR1I2
SCHEMBL27698000 0.75 MEN1 (0.42) KMT2AMEN1VHLALDH1A1NR1I2
SCHEMBL18256146 0.74 PPARA (0.37) ALDH1A1KDM4EUSP2LMNAMMP9
SCHEMBL27247447 0.73 MAPT (0.38) KMT2AALDH1A1KDM4EUSP2LMNA
SCHEMBL16232507 0.71 VHL (0.43) KMT2AMEN1VHLALDH1A1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107709323-B Hydroxyl purine compound and application thereof 广东众生睿创生物科技有限公司 2020-11-20 CN disclosed
US-10278973-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2019-05-07 US disclosed
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-24 US disclosed
EP-3299371-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-28 EP disclosed
EP-3299371-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-28 EP disclosed
US-9593071-B2 Process for the preparation of gamma amino acids and intermediates used in said process ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2017-03-14 US disclosed
WO-2016184312-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF 南京明德新药研发股份有限公司 2016-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF PNP, PDE7A, PDE2A KMT2A 3576/4885MEN1 3692/4885VHL 3411/4885
US-10278973-B2 Hydroxyl purine compounds and use thereof PNP, PDE7A, PDE2A KMT2A 3576/4885MEN1 3692/4885VHL 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.